Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma - Poll - MDSpire

Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma

  • By

  • Hao Su

  • Xinyu Zhao

  • Xiaoyu Qin

  • Xu Zhou

  • Mianli Li

  • Lijun Tian

  • June 19, 2026

  • 0 min

Share

Original Source(s)

Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma

  • by Hao Su, Xinyu Zhao, Xiaoyu Qin, Xu Zhou, Mianli Li, Lijun Tian

  • June 19, 2026

Related Content

Case Report: Exchange transfusion for hemolytic anemia and acute kidney injury associated with hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin in a patient with hepatocellular carcinoma

Epilepsy characteristics and outcomes in patients with pleomorphic xanthoastrocytomas

2026 AACR Renal Cell Carcinoma Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the renal cell carcinoma clinical updates you need to know from AACR 2026.

  • June 17, 2026

  • 1 min